<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
<journal-title-group>
<journal-title>Nature Communications</journal-title>
</journal-title-group>
<issn pub-type="epub">2041-1723</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31748530</article-id>
<article-id pub-id-type="pmc">6868241</article-id>
<article-id pub-id-type="publisher-id">13212</article-id>
<article-id pub-id-type="doi">10.1038/s41467-019-13212-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ranking of non-coding pathogenic variants and putative essential regions of the human genome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8558-9373</contrib-id>
<name>
<surname>Wells</surname>
<given-names>Alex</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4274-6084</contrib-id>
<name>
<surname>Heckerman</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0232-8053</contrib-id>
<name>
<surname>Torkamani</surname>
<given-names>Ali</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2634-9158</contrib-id>
<name>
<surname>Yin</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9087-526X</contrib-id>
<name>
<surname>Sebat</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5435-1127</contrib-id>
<name>
<surname>Ren</surname>
<given-names>Bing</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Telenti</surname>
<given-names>Amalio</given-names>
</name>
<address>
<email>atelenti@scripps.edu</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9343-127X</contrib-id>
<name>
<surname>di Iulio</surname>
<given-names>Julia</given-names>
</name>
<address>
<email>Julia.diiulio@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Stanford University, </institution></institution-wrap>Stanford, CA 94305 USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9632 6718</institution-id><institution-id institution-id-type="GRID">grid.19006.3e</institution-id><institution>Department of Computer Sciences, </institution><institution>University of California Los Angeles, </institution></institution-wrap>Los Angeles, CA 90024 USA </aff>
<aff id="Aff3"><label>3</label>Scripps Research Translational Institute, La Jolla, CA 92037 USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Beyster Institute for Psychiatric Genomics, Department of Psychiatry, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA 92093 USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Department of Cellular and Molecular Medicine, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA 92093 USA </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Department of Pediatrics, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA 92093 USA </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000000097371625</institution-id><institution-id institution-id-type="GRID">grid.1052.6</institution-id><institution>Ludwig Institute for Cancer Research, </institution></institution-wrap>La Jolla, CA 92093 USA </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122199231</institution-id><institution-id institution-id-type="GRID">grid.214007.0</institution-id><institution>Department of Integrative Structural and Computational Biology, </institution><institution>The Scripps Research Institute, </institution></institution-wrap>La Jolla, CA 92037 USA </aff>
<aff id="Aff9"><label>9</label>Present Address: Vir Biotechnology, Inc., San Francisco, CA 94158 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>20</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>5241</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">A gene is considered essential if loss of function results in loss of viability, fitness or in disease. This concept is well established for coding genes; however, non-coding regions are thought less likely to be determinants of critical functions. Here we train a machine learning model using functional, mutational and structural features, including new genome essentiality metrics, 3D genome organization and enhancer reporter data to identify deleterious variants in non-coding regions. We assess the model for functional correlates by using data from tiling-deletion-based and CRISPR interference screens of activity of <italic>cis</italic>-regulatory elements in over 3 Mb of genome sequence. Finally, we explore two user cases that involve indels and the disruption of enhancers associated with a developmental disease. We rank variants in the non-coding genome according to their predicted deleteriousness. The model prioritizes non-coding regions associated with regulation of important genes and with cell viability, an in vitro surrogate of essentiality.</p>
</abstract>
<abstract abstract-type="web-summary" id="Abs2">
<p id="Par2">Whole genome sequencing (WGS) holds promise to solve a subset of Mendelian disease cases for which exome sequencing did not provide a genetic diagnosis. Here, Wells et al. report a supervised machine learning model trained on functional, mutational and structural features for rank-scoring and interpreting variants in non-coding regions from WGS.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Computational models</kwd>
<kwd>Genetic variation</kwd>
<kwd>Medical genomics</kwd>
<kwd>Genetics research</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par3">There is rapid improvement in the understanding of the human genome, the organization of function, and the consequences of human genetic variation. This understanding enables multiple innovations in medical genetics. For example, exome sequencing accelerates the diagnosis and contributes to the clinical management of rare genetic disorders. However, exome sequencing only examines less than 2% of the genome sequence and the current diagnostic yield stands at around 30%<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref></sup>. The role of genetics in many other rare disorders is at present unknown, and the exact mechanisms of disease remain largely unexplored. One potential mechanism is through perturbation of important regulatory regions of the genome. Recent efforts at extending the search space from the coding to the immediate regulatory regions show that new pathogenic variants can be identified in a small fraction of cases<sup><xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup>. In parallel, there are recent reports of diseases that implicate distal enhancers and changes in the three-dimensional (3D) genome structure<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Thus, the next milestones in the interpretation of the human genome sequence will emerge from the analysis of functional consequences of genetic variants in the non-protein coding (here in referred to as non-coding) genome—the remaining 98% of genome sequence that includes the regulatory machinery. As previously done for coding genes<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, we define a non-coding genomic element as putative essential when loss of its function may compromise viability of the individual or results in profound loss of fitness or in disease.</p>
<p id="Par4">Interpretation of the non-coding genome requires the identification of landmarks, features and structures, the same principles that aid the interpretation of the coding genome. Genome-wide epigenomic maps have revealed hundreds of thousands of regions showing signatures of enhancers, promoters and other gene-regulatory elements<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. However, the high-resolution dissection of functionally relevant nucleotides as well as the hallmarks of essentiality in the non-coding genome remain limited at present<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Multiple sources of biochemical, genetic and evolutionary data convey functional information on the non-coding genome<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. These data are used by different scoring algorithms<sup><xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR22">22</xref></sup> that aim at ranking variants according to their predicted deleteriousness. The accuracy of these methods typically increases with ensemble-based classifiers<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> which integrate multiple models. The precision of functional and deleteriousness prediction can be further increased by learning from novel data sources. Sources of data that have not been included in previous analyses include studies of the patterns of human-specific constraints that are revealed by population genomic analyses<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, analyses of 3D organization of the genome (e.g., promoter capture Hi-C)<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, and from high-throughput screens of enhancer function<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. In this work, we implement state-of-the art machine learning tools to rank-classify putative essential elements of the non-coding genome with an emphasis on the contribution of new data modalities. We then use tiling array deletion and CRISPR interference (CRISPRi) data to assess the possible functional relevance of the predictions. Lastly, we assess the predictive tool in two clinical settings: structural variants associated with the autism spectrum disorder (ASD) and in a developmental disorder resulting from the disruption of the regulatory machinery. The study provides a tool for the interpretation of variants in the non-coding genome and for the prioritization of genomic regions that are associated with critical functions. The study design is summarized in Supplementary Fig. <xref ref-type="media" rid="MOESM2">1</xref>.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results and Discussion</title>
<sec id="Sec3">
<title>Training a model to identify putative essential non-coding elements</title>
<p id="Par5">To train a supervised machine learning model, we included non-coding pathogenic variants from ClinVar<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and Human Gene Mutation Database (HGMD)<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (<italic>N</italic> = 782, Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">2</xref>). The set of control variants was built by using all variants from gnomAD (<ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link>) with allele frequencies &gt;1% across populations and sub-selecting (<italic>N</italic> = 9516) those that matched the pathogenic variant set based on distance to splice sites and genomic element distribution. For validation, we used non-coding pathogenic variants not included in the original dataset, from a new release of ClinVar and HGMD (total of <italic>N</italic> = 286, including <italic>N</italic> = 77 mapping to non-coding RNAs (ncRNAs); see Methods, Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">2</xref>). To mitigate bias in the selection of pathogenic and control variants, we use multiple strategies: (i) the control variants are selected to be the closest common variants matching the pathogenic variant in terms of genomic element and distance to splice site, (ii) a minimum distance of 500 bp is allowed between pathogenic variants to prevent overweighting of some genomic regions in the model, but still allowing for sub-genic genomic element resolution, (iii) the model is trained and tested on non-overlapping chromosomic regions to counteract the potential over-training of some genes.</p>
<p id="Par6">We trained an XGBoost model, an implementation of gradient-boosted decision trees consisting of a collection of decision trees, where a node in a single decision tree splits the training data into subsets (deleterious versus benign). During testing, new variants with the same feature sets were given to each tree to make a prediction (putative essential or non-essential). The outputs of each tree were combined (“ensembling”) to generate a final prediction. Each variant in the dataset was annotated with 38 features from four major categories (Supplementary Data <xref ref-type="media" rid="MOESM5">2</xref>). (i) Essentiality features, such as context-dependent tolerance score (CDTS)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> and probability of loss-of-function intolerance (pLI)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, among others. The latter was used by mapping each non-coding genetic variant to the closest gene and assigning the gene essentiality score of that gene to the corresponding variant. (ii) Chromatin structure features, such as chromosome conformation<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup> data used either as a binary indicator to denote whether or not a given non-coding genomic position physically interacts with gene promoters, or as a continuous feature, by attributing the respective gene essentiality of the associated promoter to the distal interacting region. The loop and anchor features were also used as discrete values representing the number of cell lines where they were identified. (iii) Gene expression-related features, such as readout of high-throughput enhancer functional screens<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, and (iv) existing non-coding deleteriousness metrics: CADD<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, ncEigen<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, FATHMM<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, FunSeq2<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, LINSIGHT<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, ORION<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, ReMM<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and ncRVIS<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
<p id="Par7">We scored the non-coding regions genome-wide. The result of this process was a score (ncER, non-coding essential regulation) for each nucleotide, ranging from 0 (non-essential) to 1 (putative essential). We evaluated the model performance on a test set comprising 20% of the data through fivefold cross validation and assessed the generalization of the model on two independent non-overlapping sets, consisting of hold-out HGMD and ClinVar variants, for validation of the performance of the classifier (see Methods, Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">2</xref>). ncER reached a receiver operating characteristic (ROC) AUC of 88% and a precision-recall (PR) AUC of 41% on the test set (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). We then aimed at understanding the collective and individual contribution of the new features, namely essentiality, 3D genome organization and gene expression features, compared to the prediction achieved with all previously used scores. A model trained solely with the new features performed similarly to a model trained with previously published metrics (Fig. <xref ref-type="fig" rid="Fig1">1a, b</xref>, Supplementary Fig. <xref ref-type="media" rid="MOESM2">3</xref>), but most importantly the addition of the new features in the model increased both ROC and PR AUCs by at least 8%. The univariate importance of each input feature in the model is displayed in Fig. <xref ref-type="fig" rid="Fig1">1c</xref>. Most of the features (30 out of 38) in the model contributed to the score. The top contributing new features were Orion<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and CDTS<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> that measure human-specific genomic constrain. Because of sparsity of some of the data (for example, pcHi-C and Vista enhancers), some of the features did not contribute to the model as few variants mapped to informative positions. The model generalized to the independent validation datasets, including to a set of pathogenic variants mapping to ncRNAs, achieving an ROC-AUC ranging from 84 to 93% and a PR-AUC ranging from 45 to 65% (Supplementary Fig. <xref ref-type="media" rid="MOESM2">4</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Ensemble learning for the prediction of deleterious variants in the non-coding genome. Performance ROC-AUC (<bold>a</bold>) and PR-AUC (<bold>b</bold>) on the test set (<italic>N</italic> = 136 non-coding pathogenic and <italic>N</italic> = 2017 control variants) of a model trained only with published deleteriousness metrics (blue), only with new features, namely essentiality, 3D genome organization and gene expression features (orange) and with both new features and published metrics (green, ncER). The importance of the various input features in the ncER model is shown in <bold>c</bold>. Blue, published scores; green, new essentiality features; red, new 3D chromatin structure features; orange, new regulatory/functional screen features. Panel <bold>d</bold> shows the distribution of ncER percentiles for an independent set of 137 curated non-coding pathogenic Mendelian variants compared to a set of singletons from gnomad matched by genomic element and distance to splice sites. There is statistically significant enrichment for both dominant (<italic>N</italic> = 85) and recessive (<italic>N</italic> = 52) non-coding pathogenic variants in high ncER percentiles. <italic>p</italic> Values were computed with Fisher's exact test. ROC receiver operating characteristic, PR precision-recall, AUC area under the curve</p></caption><graphic id="d29e624" xlink:href="41467_2019_13212_Fig1_HTML"></graphic></fig></p>
<p id="Par8">We then examined the nature of the high ncER score regions of the genome based on different ncER percentile thresholds (99.9th, 99.5th, 99th and 95th percentiles, representing 1.7, 9.9, 21.4 and 117 Mb of cumulative sequence not overlapping protein coding regions). The distribution of genomic elements at each threshold is displayed in Supplementary Figs. <xref ref-type="media" rid="MOESM2">5</xref>A and <xref ref-type="media" rid="MOESM2">5B</xref>. All types of genomic elements were represented in the highest ncER score bins of the genome, although <italic>cis</italic>-regulatory and enhancer sequences were enriched in the highest percentiles. High ncER score regions were of small size, with the most common size range being single nucleotides (Supplementary Fig. <xref ref-type="media" rid="MOESM2">5C</xref>). To have an overview of the putative function of high ncER score regulatory regions, we did pathway analyses for the set of genes (<italic>N</italic> = 701) with at least one promoter nucleotide in the top 99.9% ncER values. The most significant enriched biological process GO terms included development and regulation of gene expression, such as heart development and negative regulation of gene expression (Supplementary Fig. <xref ref-type="media" rid="MOESM2">6</xref>). Finally, we examined the distribution of ncER percentile for an independent curated set of non-coding Mendelian variants (see Methods, Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> and  <xref ref-type="media" rid="MOESM4">3</xref>, and Supplementary Fig. <xref ref-type="media" rid="MOESM2">2</xref>). The majority of mutations (86%) had ncER values above the 95th percentile, and 58% above the 99th percentile; a 5.9- and 15.4-fold enrichment over matched singleton variants, respectively (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). Similarly, we observed a significant shift to higher ncER values when assessing genome-wide association studies (GWAS) hit single-nucleotide variants (SNVs) (see Methods, Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">2</xref>) compared to a control set of common variants (Supplementary Fig. <xref ref-type="media" rid="MOESM2">7</xref>).</p>
<p id="Par9">In summary, a model that trains on novel genomic features (essentiality, 3D organization, expression) adds precision to previous models that trained on partially orthogonal features (biochemistry, conservation). The model performs well in testing and generalization using independent sets of human non-coding disease variants.</p>
</sec>
<sec id="Sec4">
<title>Functional correlates of highly ranked non-coding regions</title>
<p id="Par10">To assess whether ncER signals effectively identified important non-coding regions, we analyzed two sets of functional data. The first analysis used high-throughput CRISPRi data from 1.29 Mb of sequence in the vicinity of two essential transcription factor genes, <italic>GATA1</italic> and <italic>MYC</italic><sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. The library deployed more than 80,000 single guide RNA (sgRNAs) pairs tiled across the genomic loci. The readout of the study was cellular proliferation of K562 erythroleukemia cells. To profile the region, we extracted the highest ncER score for each probe. <italic>GATA1</italic> or <italic>MYC</italic> regions were characterized by a high ncER score, with the median being in the 94th percentile (Fig. <xref ref-type="fig" rid="Fig2">2a, b</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">8</xref>)—which is consistent with the biological importance of the loci. Within this region, we observed a further shift to a median 99th ncER percentile for the regions targeted by the functional pairs of sgRNA probes (<italic>p</italic> &lt; 2.2e−16, compared to non-functional probes—those with less than twofold change decrease in cell viability). Importantly, we removed all sgRNA probes that overlapped with an exon (1746 of 77,368, 2.3%), Fig. <xref ref-type="fig" rid="Fig2">2b</xref>. The parameters of predictive performance and accuracy of ncER are shown in Supplementary Table <xref ref-type="media" rid="MOESM2">1</xref>. In summary, the sequences that control cellular proliferation, cell viability and gene expression of <italic>GATA1</italic> and <italic>MYC</italic> reside in the regions with high ncER scores.<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of experimental functional assays with in silico ncER predictions. <bold>a</bold> CRISPRi effect on cell viability (75,622 sgRNA probes pairs) from Fulco et al.<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> and the corresponding maximum ncER score across the <italic>GATA1</italic> and <italic>MYC</italic> loci. Accuracy at four ncER thresholds is shown in yellow, orange, red and dark-red respectively for the 95th, 99th, 99.5th and 99.9th percentiles. <bold>b</bold> Distribution of maximum ncER at different bins of cell viability (0 to less than −3 log2 fold change). The boxplot’s central line represents the median, the bounds represent the 25th and 75th percentile, and the whiskers extend up to 1.5 the interquatile range from the respective bounds. <italic>p</italic> Values were computed with independent two-group Mann–Whitney unpaired test. <bold>c</bold> Fraction of regions with at least one high ncER score, as defined by four different ncER percentile thresholds. CRESTseq peaks are shown in red (<italic>N</italic> = 45), random matched sized in silico regions extracted from the same locus (“random same locus, <italic>N</italic> = 4500) in dark gray and random matched sized in silico regions extracted genome-wide (“random GW”, <italic>N</italic> = 4500), in light gray. <italic>p</italic> Values were computed with Fisher's exact test. FC fold change, CRESTseq <italic>cis</italic>-regulatory elements by tiling-deletion and sequencing, GW genome-wide, CRISPRi clustered regularly interspaced short palindromic repeats interference</p></caption><graphic id="d29e760" xlink:href="41467_2019_13212_Fig2_HTML"></graphic></fig></p>
<p id="Par11">The second dataset corresponded to high-throughput scanning for <italic>cis</italic>-regulatory elements by tiling-deletion and sequencing (11,570 CREST-seq probes)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. The area investigated encompassed 2-Mb of the <italic>POU5F1</italic> locus in human embryonic stem cells. <italic>POU5F1</italic> encodes a transcription factor that plays a key role in embryonic development and stem cell pluripotency. Knockout of <italic>POU5F1</italic> is associated with embryonic mortality in the mouse and scores as an essential gene in humans (pLI score of 0.89)<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. Thus, <italic>POU5F1</italic> is expected to use regulatory elements with features of essentiality<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. The parameters of predictive performance and accuracy of ncER are shown in Supplementary Table <xref ref-type="media" rid="MOESM2">2</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">9</xref>. By extracting peaks of signal, CREST-seq identified 45 <italic>cis</italic>-regulatory elements, including 17 previously annotated as promoters of unrelated genes that, like typical enhancers, form extensive spatial contacts with the <italic>POU5F1</italic> promoter. The CREST-seq peaks encompassed a wide range of sizes and were longer than the probed deletions, therefore increasing the likelihood of having at least one nucleotide with high ncER percentile within the peaks. To account for the longer size, we averaged the ncER signal over 10 bp bins and reextracted the percentiles genome-wide. These binned scores were used for the remainder of the analyses. The 45 enhancers of <italic>POU5F1</italic> were significantly more likely have high ncER scores compared to random genomic loci of matched size (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). For example, 31% of <italic>POU5F1</italic> enhancers reside in regions with ncER &gt;99th percentile, compared to 7–16% for random genomic regions matched to enhancer size, <italic>p</italic> ≤ 0.01. Similarly, the enhancers contained the highest scored regions within the locus in permutation analysis (Supplementary Fig. <xref ref-type="media" rid="MOESM2">10</xref>).</p>
<p id="Par12">In summary, ncER has a good performance for the identification of deleterious variants in the non-coding genome. ncER can also identify non-coding regions associated with cell viability, an in vitro surrogate of essentiality<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, and with regulation of an essential gene. Thus, we speculated that ncER may help map critical regulatory and structural elements of the non-coding genome in the setting of human disease.</p>
</sec>
<sec id="Sec5">
<title>Mapping important regulatory elements in clinical diseases</title>
<p id="Par13">We hypothesized that severe genetic diseases that do not have causal variants in the coding region could result from damage to critical non-coding functional elements. To investigate this concept, we chose two different models that represent challenges for the accurate mapping of functional sites in relation to disease: (i) the identification of the critical areas within non-coding structural variants/deletions associated with ASD, and (ii) the impact of reorganization of topologically associated domains (TADs) in the setting of a human developmental disorder that has been modeled in the mouse.</p>
<p id="Par14">For the first disease model, we assessed a set of cis-regulatory structural variants that were associated with ASD in our previous study (Brandler et al.)<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. We evaluated deletions from 120 probands and from 16 unaffected siblings. The median ncER percentile were not higher in probands compared to unaffected siblings (median percentile 59.0 compared to 76.1, <italic>p</italic> = 0.11, independent two-group Mann–Whitney unpaired test). However, ASD probands were more likely to carry structural variants with localized high functional domains compared to healthy siblings (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). For example, 25% of the deletions in probands contained regions with ncER &gt; 99th percentile compared to 19% for deletions in unaffected siblings (n.s.), and 11% in 13,600 random genomic regions matched to the size of the deletions (<italic>p</italic> = 8.9e−06, Fisher’s exact test). The fraction of deletions with high ncER score domain (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>) and the cumulative number of nucleotides with high ncER score were consistently higher in ASD proband (Supplementary Figs. <xref ref-type="media" rid="MOESM2">11</xref> and <xref ref-type="media" rid="MOESM2">12</xref>). In summary, we observe a general trend of enrichment for high ncER regions in deletions in probands (Supplementary Fig. <xref ref-type="media" rid="MOESM2">13</xref>) and propose their location (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). This is consistent with recent data on potentially disruptive mutations among conserved non-coding sequences and a call for improved variant detection and functional classification of non-coding variants<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Because the ncER score is trained with severe deleterious and unfitting variants, it may be less sensitive to changes observed in candidate indels in ASD.<fig id="Fig3"><label>Fig. 3</label><caption><p>Mapping of critical domains in disease models. <bold>a</bold> Fraction of deletions with at least one high score ncER bin, defined at four different ncER percentile thresholds. Autism and ASD deletions are shown in red (ASD, <italic>N</italic> = 120), control deletions in dark gray (control, <italic>N</italic> = 16) and random size-matched in silico deletions extracted genome-wide in light gray (random, <italic>N</italic> = 13,600). See Supplementary Fig. <xref ref-type="media" rid="MOESM2">9</xref> for distribution of other sizes of deletions. <italic>p</italic> Values were computed with Fisher's exact test. <bold>b</bold> Schematic illustration of 15 unique &lt;1 kb deletions (gray bars) identified in autism and ASD probands that harbor high score ncER regions (highlighted in yellow, orange, red and dark red, based on the ncER thresholds). The corresponding genomic elements are displayed under the deletions. Introns are shown in blue, ncRNA in magenta, <italic>cis</italic> regulatory in dark green, enhancers and others regulatory elements in light green and histone marks in light pink (see Methods for categorization of genomic element classes). <bold>c</bold> The upper panel pictogram is adapted from ref. <sup><xref ref-type="bibr" rid="CR37">37</xref></sup> and illustrates the human <italic>IHH</italic> genomic locus associated with developmental defects including craniosynostosis and synpolydactyly<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. It harbors the nine enhancers identified in mice (from Will et al.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>), represented in dark red ovale shapes. Lower panel, UCSC genome browser view of the region in the locus. The gray box inset highlights the region of high ncER scores across human pathogenic duplications, the blue box highlights the maximal overlap of genomic lesions in humans, and the green box that includes the <italic>IHH</italic> region present in duplications causing syndactyly Leuken type engineered in Will et al.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. <bold>d</bold> Fraction of regions with at least one high score ncER, defined by four different ncER percentile thresholds. Mouse to human mapped enhancers are shown in red (“functional”, <italic>N</italic> = 9), random size-matched in silico deletions extracted from the same locus (“random same locus”, <italic>N</italic> = 900) in dark gray and random size-matched in silico deletions extracted genome-wide (“random GW”, <italic>N</italic> = 900) in light gray. <italic>p</italic> Values were computed with Fisher's exact test. GW genome-wide, ASD autism spectrum disorder</p></caption><graphic id="d29e946" xlink:href="41467_2019_13212_Fig3_HTML"></graphic></fig></p>
<p id="Par15">Next, we chose a human disease that involves the rearrangement of the regulatory landscape of <italic>IHH</italic> (encoding Indian hedgehog). Brachydactyly A1 is characterized by developmental defects including craniosynostosis and synpolydactyly<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Will et al.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> identified nine enhancers with individual tissue specificities in the digit anlagen, growth plates, skull sutures and fingertips. The <italic>IHH</italic> region in humans shares a common structure with the mouse locus that was used for the model by Will et al.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. In their study, consecutive deletions resulted in growth defects of the skull and long bones that confirmed that the enhancers function in an additive manner. Deletions and duplications caused dose-dependent upregulation and misexpression of <italic>Ihh</italic>, leading to abnormal phalanges, fusion of sutures and syndactyly. We identified the critical enhancers to reside in an extensive region of high ncER scores, including for the regions shared across human duplications associated with disease (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>, blue box). Within the locus, the critical enhancers were also endowed with high ncER scores (Fig. <xref ref-type="fig" rid="Fig3">3d</xref>). For example, 100% of the enhancers were at ncER &gt; 99th percentile, compared to 10% for random genomic regions matched to size, <italic>p</italic> = 1.1e−09, Fisher’s exact test (Supplementary Fig. <xref ref-type="media" rid="MOESM2">14</xref>).</p>
<p id="Par16">The value of a predictive model that generates scores of pathogenicity depends of the validity of the training sets of pathogenic variants and of the genomic features. The performance of ncER is thus dependent on a limited number of known non-coding pathogenic variants and on the quality of annotation. Our work uses numerous training and validation strategies: independent sets of ClinVar/HGMD and curated Mendelian variants, ASD structural variants, and GWAS variants, as well as functional assessment on two sets of experimental functional data and on a model of craniosynostosis and synpolydactyly. The score can also be limited by ascertainment by proximity: the non-coding pathogenic variants are close to coding regions because that is where they may be primarily searched for. However, our work supports that ncER generalizes to sets of variants with different genomic distributions. We also acknowledge the incomplete orthogonal nature of some of the informative features used in the models. However, Gradient Boosting Trees are well equipped to handle redundant information. There is no doubt that the model will improve in precision with the inclusion of novel features and increasing numbers of annotated non-coding genome variants.</p>
<p id="Par17">More generally, this work aims at ranking non-coding regions for downstream analysis. We have recently reported on the transcription factor (Myogenic Differentiation 1) MYOD-directed re-configuration of chromatin interactions. We show that MYOD-DNA binding is favored at highly constrained genomic sequences enriched in pathogenic variants<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. This and recent work<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> contribute to the debate about reconciling redundancy and conservation in the non-coding genome. Work on developmentally expressed genes supports the concept of functionally redundant enhancers in mammalian genomes<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Osterwalder et al.<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> indicates that redundancy reduces the likelihood of severe consequences resulting from genetic or environmental challenge. However, Osterwalder et al.<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> also suggest that enhancers can be under purifying selection over evolutionary time and be relevant for organismal fitness under specific pressures because of their contribution to overall gene expression levels. We have in the past indicated that essential genes will use proximal and distant regulatory elements that are conserved and constrained—thus representing putative essentiality in the non-coding genome<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. The current model supports the prioritization of variants and regions across the non-protein coding human genome for diagnostics and for functional analysis.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Methods</title>
<sec id="Sec7">
<title>Training features</title>
<p id="Par18">To train the model, we leveraged a total of 38 features from four major categories: (i) gene essentiality, (ii) 3D chromatin structure, (iii) gene expression and other regulatory/functional data and (iv) existing variant pathogenicity/deleteriousness scores. A complete list of features along with their descriptions and accession links can be found in Supplementary Data <xref ref-type="media" rid="MOESM5">2</xref>.</p>
<p id="Par19">We have previously identified a coordination of constrains between genes and their respective <italic>cis</italic> and distal regulatory elements<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. We implement this concept in the present study by including the following essentiality features: (i) CDTS (our recently developed approach to score the non-coding genome essentiality, based on human genetic diversity<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, (ii) pLI<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, (iii) haploinsufficiency score<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, (iv) gene dosage sensitivity score from ClinGen<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>, (v) autosomal dominant or recessive categorization<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> and (vi) Online Mendelian Inheritance in Man (OMIM) association<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. For the metrics that solely provide scores for the genic portion of the genome, the respective essentiality features were calculated by mapping each non-coding genomic position to the nearest gene and assigning the corresponding essentiality metric score to the genomic position.</p>
<p id="Par20">Chromatin 3D structure features included (i) nucleosome positioning extracted from MNase data (<ext-link ext-link-type="uri" xlink:href="https://www.encodeproject.org/">https://www.encodeproject.org/</ext-link>), (ii) multiple cell type anchor, loop and domain regions extracted from Hi-C data<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, (iii) frequently interacting regions (FIRE) and TADs extracted from Schmitt et al.<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> and (iv) distal enhancer-TSS associations extracted from CAGE pairwise expression correlation (FANTOM)<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. The 3D organization features were either used as binary indicators to denote whether or not a given non-coding genomic position physically interacted with gene promoters, or as discrete values representing the number of cell lines were the structures were identified. Finally, to combine both essentiality and chromatin structure features, we created distal essentiality features, by attributing the respective coding gene essentiality score (pLI) to distal regulatory elements identified through pcHi-C or CAGE pairwise expression correlations.</p>
<p id="Par21">The model used gene expression, long non-coding RNA (lncRNA) annotations and functional regulatory data that have not been used by other existing metrics. Those included (i) median gene expression and variance across tissues (GTEx)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, (ii) functionally tested genomic regions with enhancer activity identified through (ChIP-)STARR-seq experiments<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR50">50</xref></sup> or validated with transgenic mice<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> and (iii) lncRNAs identified through CAGE and transcriptome analysis<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>.</p>
<p id="Par22">Lastly, variant pathogenicity/deleteriousness scores used in the model included CADD<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, ncEigen<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, FATHMM<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, FunSeq2<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, LINSIGHT<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, ncRVIS<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, Orion<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and ReMM<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. We downloaded pre-computed genome-wide scores for each of these metrics (hg19 reference build). In the minority of cases where a per alternative variant score was provided, we used the most “deleterious” value at each position. For the metrics that solely provide scores for the genic portion of the genome, the respective features were calculated by mapping each non-coding genomic position to the nearest gene and assigning the corresponding metric score to the genomic position.</p>
</sec>
<sec id="Sec8">
<title>Training variant set</title>
<p id="Par23">We used a total of 10,298 SNVs to train the model. The pathogenic dataset comprised non-coding SNVs, located at least 10 bp from the nearest splice site, obtained from HGMD (2016_R1)<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and ClinVar (July 2016)<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. The selection criteria for HGMD SNVs were “DM and high” tags, while for ClinVar, SNVs had to be labeled as “Pathogenic” or “Likely Pathogenic”, with star 1 or more and no conflicting assertion. HGMD was further filtered out for variants overlapping SNVs annotated as “benign” or “likely benign” in ClinVar (with star 1 or more and no conflicting assertion). Finally, only variants that were not within 500 bp of another pathogenic variants were retained (<italic>N</italic> = 782). The size of 500 bp was fixed to the non-genic feature with the lowest resolution (CDTS), to prevent overweighting of some genomic regions in the model, but still allowing for sub-genic genomic element resolution. In the presence of a cluster of variants, the variant with the smallest start coordinate was selected, followed by the next variant with at least 500 bp distance from the selected variant, etc. The pathogenic variants used to train the model are provided in Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> (and referred to as “training” in the variant set column). The control genomic training set consisted of 9516 variants chosen from a larger set of variants that were present in the gnomAD dataset at an allelic frequency &gt;1% and matched for the distance to the nearest splice sites and genomic elements. The matching was performed as follows: all pathogenic variants and gnomAD variants with allelic frequency &gt;1% were annotated with their respective distance to the closest splice site and the genomic element they mapped to (see Reference build, annotation and genomic element categorization section). For each pathogenic variant, the subset of control variants falling within the same genomic element was extracted. Within this subset, the closest 15 control variants with the most similar distance to splice site as compared to the pathogenic variant were kept. Finally, duplicated control variants (if any) and falling within 500 bp of another control variant were removed from the final set. A total of 80%/20% of the variants were, respectively, used as training/test sets. In addition, to prevent overfitting, the training/test set variants were split per chromosome regions as follows: the test set encompassed pathogenic variants located on chromosomes 1 (upstream-centromeric region), 10, 19 (upstream-centromeric region), 6 (downstream-centromeric region) and X (downstream-centromeric region), while the training set included the remainder of the chromosomes and/or chromosomic regions. The pathogenic variants used to test the model are provided in Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> (and referred to as “test” in the variant set column).</p>
</sec>
<sec id="Sec9">
<title>Machine learning model</title>
<p id="Par24">We trained an XGBoost model in order to differentiate between pathogenic and control genomic positions in our training set. Hyperparameters were tuned using fivefold cross validation and a randomized search method. A total of 1000 sets of randomly selected hyperparameters were evaluated using fivefold cross validation, and the model that achieved the highest ROC-AUC score was selected. These hyperparameters were then used to train the final model on the entirety of the training set. After hyperparameter tuning, we found that using 32 estimators, a maximum depth of 31, a learning rate of 0.31, and a minimum child weight of 6.17 maximized model performance. We evaluated our model with ROC AUC and PR AUC on the test set (representing 20% of the data).</p>
<p id="Par25">We annotated each position in the genome with our set of features and used the tuned XGBoost model to make a functionality prediction at each genomic position to score the entire genome. Of note, the model is trained to assess variants and regions of the non-coding genome, and therefore is not relevant for the scoring of protein coding regions.</p>
</sec>
<sec id="Sec10">
<title>Validation sets</title>
<p id="Par26">The generalization of the model was assessed on two independent sets of variants. The non-coding pathogenic sets included 209 and 77 new HGMD and ClinVar variants<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> mapping outside/inside ncRNA genes (HGMD 2017_R2 and ClinVar January 2018), at least 500 bp from any pathogenic variants from the training and test sets and from one each other. The control genomic validation sets consisted respectively of 2,090 and 770 variants in the gnomAD dataset at an allelic frequency &gt; 1% and matched to the pathogenic sets for the distance to the nearest splice sites and genomic elements as explained above and at least 500 bp from any control variants from the training and test sets and from one each other. The pathogenic variants used to validate the model are provided in Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> (and referred to as “generalization_other” and “generalization_ncRNA” in the variant set column).</p>
</sec>
<sec id="Sec11">
<title>Mendelian variants</title>
<p id="Par27">To explore ncER percentile distribution of highly likely pathogenic variants, we used a manually curated set of pathogenic non-coding variants associated with Mendelian traits<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and selected those falling at least 500 bp from any pathogenic variants from the training/test sets, yielding a set of 85 dominant and 52 recessive non-coding pathogenic variants. The pathogenic Mendelian variants are provided in Supplementary Data <xref ref-type="media" rid="MOESM4">3</xref>. The control genomic variants (<italic>N</italic> = 13,659) consisted of singleton variants from the gnomAD whole-genome sequencing datasets matched to the pathogenic sets for the distance to the nearest splice sites and genomic elements as explained above.</p>
</sec>
<sec id="Sec12">
<title>GWAS variants</title>
<p id="Par28">We used GWAS hit SNVs from GWAS catalog (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/gwas">https://www.ebi.ac.uk/gwas</ext-link>; downloaded on 4 April 2018). We parsed the data to retain only the most significant SNV per locus per phenotype and per study and keep a maximum of one variant per genomic coordinate, yielding to 1785 phenotype-associated variants. GWAS variants are provided in Supplementary Data <xref ref-type="media" rid="MOESM3">1</xref> (and referred to as “gwas” in the variant set column). The control genomic variants (<italic>N</italic> &gt; 5 million) consisted of common variants (allelic frequency &gt; 0.05) from the gnomAD whole-genome sequencing datasets and matched to the phenotype-associated set for the distance to the nearest splice sites and genomic elements as explained above.</p>
</sec>
<sec id="Sec13">
<title>Reference build, annotation and genomic element categorization</title>
<p id="Par29">All input features and the model were mapped to the human reference build hg19. To investigate the element distribution, we built an annotation track that combined annotations from GenCode (v.27 mapped to GRCh37) and ENCODE (annotated features and multicell regulatory elements, Ensembl v91 Regulatory Build) and used a prioritization scheme to assign each genomic position a single annotation category (described in ref. <sup><xref ref-type="bibr" rid="CR24">24</xref></sup>). In short, the prioritization was as follows: CDS &gt; Intron (<italic>cis</italic>—within 10 bp of a splice site) &gt; ncRNA &gt; UTR &gt; multicell regulatory &gt; Intron (distal—more than 10 bp of a splice site) &gt; annotated features. For Fig. <xref ref-type="fig" rid="Fig3">3</xref>, <italic>Intron</italic> refers to intronic regions (from protein coding or non-coding genes), <italic>ncRNA</italic> refers to exonic regions of non-coding RNAs, <italic>Cis Regulatory</italic> encompasses promoters and untranslated regions (UTRs), <italic>Enhancers and Others</italic> encompasses promoter flanking regions, enhancers, open chromatin, CTCF and other transcription factor binding sites, <italic>Intergenic</italic> refers to unannotated regions and <italic>Histone marks</italic> encompasses H3K9me3 and/or H3K27me3 as well as other histone marks combinations.</p>
</sec>
<sec id="Sec14">
<title>ncER score</title>
<p id="Par30">Two sets of ncER percentile scores were computed. The first with nucleotide resolution and the second where raw ncER scores were averaged over 10 bp bins and then expressed as percentiles genome-wide. Both sets of percentiles are provided at <ext-link ext-link-type="uri" xlink:href="https://github.com/TelentiLab/ncER_datasets">https://github.com/TelentiLab/ncER_datasets</ext-link> and can be browsed directly at OMNI (<ext-link ext-link-type="uri" xlink:href="https://www.ai-omni.com/">https://www.ai-omni.com/</ext-link>). Intersection of ncER score with other datasets was performed using bedops utility (v2.4.30)<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>.</p>
</sec>
<sec id="Sec15">
<title>External datasets</title>
<p id="Par31">The CRISPRi coordinates and scores used for analyses displayed in Fig. <xref ref-type="fig" rid="Fig2">2a, b</xref> and Supplementary Fig. <xref ref-type="media" rid="MOESM2">8</xref> were obtained from Fulco et al.<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://science.sciencemag.org/highwire/filestream/686019/field_highwire_adjunct_files/2/aag2445_Table_S2.xlsx">http://science.sciencemag.org/highwire/filestream/686019/field_highwire_adjunct_files/2/aag2445_Table_S2.xlsx</ext-link>). As recommended in their paper, the CRISPRi scores were smoothed over 20 subsequent pairs. Only regions that were assessed by at least 20 different pairs and &lt;1 kb long (to prevent size biases) were retained for analysis, resulting in a total of <italic>N</italic> = 77,368 remaining probed pairs. After removing probes overlapping with protein coding region, we retained 75,622 sgRNA pairs.</p>
<p id="Par32">CREST-seq peaks coordinates used for analyses displayed in Fig. <xref ref-type="fig" rid="Fig2">2c</xref> and Supplementary Fig. 10 were obtained from Diao et al.<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://media.nature.com/original/nature-assets/nmeth/journal/v14/n6/extref/nmeth.4264-S7.xlsx">https://media.nature.com/original/nature-assets/nmeth/journal/v14/n6/extref/nmeth.4264-S7.xlsx</ext-link>). Statistical enrichment of the 11,570 tested sgRNA pairs used for analyses in Supplementary Fig. 9 were also obtained from ref. <sup><xref ref-type="bibr" rid="CR33">33</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://media.nature.com/original/nature-assets/nmeth/journal/v14/n6/extref/nmeth.4264-S5.xlsx">https://media.nature.com/original/nature-assets/nmeth/journal/v14/n6/extref/nmeth.4264-S5.xlsx</ext-link>). The locus used for random extraction of same size regions was chr6:30132133–32138339. The matched size random extraction (both in the same locus and genome-wide) was performed 100 times.</p>
<p id="Par33"><italic>Cis</italic> regulatory transmitted deletions used for analyses displayed in Fig. <xref ref-type="fig" rid="Fig3">3a, b</xref> and Supplementary Figs. <xref ref-type="media" rid="MOESM2">11</xref>–<xref ref-type="media" rid="MOESM2">13</xref> were obtained from Brandler et al.<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://science.sciencemag.org/highwire/filestream/708877/field_highwire_adjunct_files/9/aan2261_TableS7.xlsx">http://science.sciencemag.org/highwire/filestream/708877/field_highwire_adjunct_files/9/aan2261_TableS7.xlsx</ext-link>, Replication CR Trans sheet). The matched size genome-wide random extraction was performed 100 times.</p>
<p id="Par34">The mouse enhancer data used for analyses displayed in Fig. <xref ref-type="fig" rid="Fig3">3c</xref> and Supplementary Fig. 14 were obtained from Will et al.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://media.nature.com/original/nature-assets/ng/journal/v49/n10/extref/ng.3939-S1.pdf">https://media.nature.com/original/nature-assets/ng/journal/v49/n10/extref/ng.3939-S1.pdf</ext-link>, Supplementary Table S<xref ref-type="media" rid="MOESM2">4</xref>). The mouse coordinates were mapped to human using CrossMap (v.0.2.5. <ext-link ext-link-type="uri" xlink:href="http://crossmap.sourceforge.net/">http://crossmap.sourceforge.net/</ext-link>) using the mm9ToHg19.over.chain.gz chain. When the mouse enhancers were mapped discontinuously to the human genome, the leftmost and rightmost coordinates in the human genome were used as start and end, respectively. The locus used for random extraction of same size regions was chr2: 219940039–220025587. The matched size random extraction (both in the same locus and genome-wide) was performed 100 times.</p>
</sec>
<sec id="Sec16">
<title>Statistics</title>
<p id="Par35">Statistical analyses and plotting were performed with R v3.4.3 (<ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>), notably using the package ggplot2 (<ext-link ext-link-type="uri" xlink:href="http://ggplot2.org/">http://ggplot2.org/</ext-link>). Data mining was performed using Python (v.2.7.11). The performance predictors in Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig2">2</xref>, Supplementary Figs. <xref ref-type="media" rid="MOESM2">3</xref>, <xref ref-type="media" rid="MOESM2">4</xref>, <xref ref-type="media" rid="MOESM2">8</xref> and <xref ref-type="media" rid="MOESM2">9</xref>, and Supplementary Tables <xref ref-type="media" rid="MOESM2">1</xref> and <xref ref-type="media" rid="MOESM2">2</xref> were assessed as follows: sensitivity or true-positive rate or recall is (TP/(TP + FN)) × 100, specificity is (TN/(TN + FP)) × 100, false-positive rate is (FP/(FP + TN)) × 100, accuracy is ((TP + TN)/(TP + TN + FP + FN)) × 100, positive predictive value or precision is (TP/(TP + FP)) × 100 and negative predictive value is (TN/(TN + FN)) × 100, where TP is a true positive, TN is a true negative, FP is a false positive and FN is a false negative. For the comparison of proportions we used Fisher’s exact test; for the comparison of distributions, we used independent two-group Mann–Whitney unpaired test or Kolmogorov–Smirnov test.</p>
</sec>
<sec id="Sec17">
<title>Reporting summary</title>
<p id="Par36">Further information on research design is available in the <xref ref-type="media" rid="MOESM6">Nature Research Reporting Summary</xref> linked to this article.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec18">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2019_13212_MOESM1_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2019_13212_MOESM2_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2019_13212_MOESM3_ESM.txt"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2019_13212_MOESM4_ESM.txt"><caption><p>Supplementary Data 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2019_13212_MOESM5_ESM.xlsx"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2019_13212_MOESM6_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2019_13212_MOESM7_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Peer review information</bold>
<italic>Nature Communications</italic> thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
</fn>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>These authors contributed equally: Amalio Telenti, Julia di Iulio.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> is available for this paper at 10.1038/s41467-019-13212-3.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank J. Fellay and A. Rausell for comments on the manuscript. Work of A.Te. is supported by the Qualcomm Foundation and the NIH Center for Translational Science Award (CTSA, grant number UL1TR002550).</p>
</ack>
<notes notes-type="author-contribution">
<title>Author contributions</title>
<p>Conception and design of the study: J.d.I, A.Te. Performed the analyses: A.W., J.d.I. Built the browser and code repositories: L.Y. Contributed methods and analytical strategies: D.H., A.To., J.S., B.R. Wrote the manuscript: J.d.I., A.Te.</p>
</notes>
<notes notes-type="data-availability">
<title>Data availability</title>
<p>Genome-wide ncER scores are also provided for download at <ext-link ext-link-type="uri" xlink:href="https://github.com/TelentiLab/ncER_datasets">https://github.com/TelentiLab/ncER_datasets</ext-link> and can be browsed directly at OMNI (<ext-link ext-link-type="uri" xlink:href="https://www.ai-omni.com/">https://www.ai-omni.com/</ext-link>).</p>
</notes>
<notes notes-type="data-availability">
<title>Code availability</title>
<p>Code for the model is provided at <ext-link ext-link-type="uri" xlink:href="https://github.com/TelentiLab/ncER_datasets">https://github.com/TelentiLab/ncER_datasets</ext-link>.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par37">The authors declare no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical exome sequencing for genetic identification of rare Mendelian disorders</article-title>
<source/>JAMA
          <year>2014</year>
<volume>312</volume>
<fpage>1880</fpage>
<lpage>1887</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2014.14604</pub-id>
<pub-id pub-id-type="pmid">25326637</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>JX</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genetic basis of Mendelian phenotypes: discoveries, challenges, and opportunities</article-title>
<source/>Am. J. Hum. Genet.
          <year>2015</year>
<volume>97</volume>
<fpage>199</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2015.06.009</pub-id>
<pub-id pub-id-type="pmid">26166479</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thevenon</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test</article-title>
<source/>Clin. Genet.
          <year>2016</year>
<volume>89</volume>
<fpage>700</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12732</pub-id>
<pub-id pub-id-type="pmid">26757139</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iglesias</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The usefulness of whole-exome sequencing in routine clinical practice</article-title>
<source/>Genet. Med.
          <year>2014</year>
<volume>16</volume>
<fpage>922</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2014.58</pub-id>
<pub-id pub-id-type="pmid">24901346</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pena</surname>
<given-names>LDM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases</article-title>
<source/>Genet. Med.
          <year>2018</year>
<volume>20</volume>
<fpage>464</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2017.128</pub-id>
<pub-id pub-id-type="pmid">28914269</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Short</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in regulatory elements in neurodevelopmental disorders</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>611</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1038/nature25983</pub-id>
<pub-id pub-id-type="pmid">29562236</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandler</surname>
<given-names>WM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Paternally inherited cis-regulatory structural variants are associated with autism</article-title>
<source/>Science
          <year>2018</year>
<volume>360</volume>
<fpage>327</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1126/science.aan2261</pub-id>
<pub-id pub-id-type="pmid">29674594</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Non-coding genetic variants in human disease</article-title>
<source/>Hum. Mol. Genet.
          <year>2015</year>
<volume>24</volume>
<fpage>R102</fpage>
<lpage>R110</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv259</pub-id>
<pub-id pub-id-type="pmid">26152199</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartha</surname>
<given-names>I</given-names>
</name>
<name>
<surname>di Iulio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Venter</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Telenti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Human gene essentiality</article-title>
<source/>Nat. Rev. Genet.
          <year>2018</year>
<volume>19</volume>
<fpage>51</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1038/nrg.2017.75</pub-id>
<pub-id pub-id-type="pmid">29082913</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roadmap Epigenomics</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative analysis of 111 reference human epigenomes</article-title>
<source/>Nature
          <year>2015</year>
<volume>518</volume>
<fpage>317</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1038/nature14248</pub-id>
<pub-id pub-id-type="pmid">25693563</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-resolution genome-wide functional dissection of transcriptional regulatory regions and nucleotides in human</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<fpage>5380</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-07746-1</pub-id>
<pub-id pub-id-type="pmid">30568279</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kellis</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining functional DNA elements in the human genome</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2014</year>
<volume>111</volume>
<fpage>6131</fpage>
<lpage>6138</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1318948111</pub-id>
<pub-id pub-id-type="pmid">24753594</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torkamani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schork</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Predicting functional regulatory polymorphisms</article-title>
<source/>Bioinformatics
          <year>2008</year>
<volume>24</volume>
<fpage>1787</fpage>
<lpage>1792</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btn311</pub-id>
<pub-id pub-id-type="pmid">18562267</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>
<source/>Nat. Genet.
          <year>2014</year>
<volume>46</volume>
<fpage>310</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>
<pub-id pub-id-type="pmid">24487276</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ionita-Laza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>McCallum</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>A spectral approach integrating functional genomic annotations for coding and noncoding variants</article-title>
<source/>Nat. Genet.
          <year>2016</year>
<volume>48</volume>
<fpage>214</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3477</pub-id>
<pub-id pub-id-type="pmid">26727659</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davydov</surname>
<given-names>EV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>
<source/>PLoS Comput. Biol.
          <year>2010</year>
<volume>6</volume>
<fpage>e1001025</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>
<pub-id pub-id-type="pmid">21152010</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer</article-title>
<source/>Genome Biol.
          <year>2014</year>
<volume>15</volume>
<fpage>480</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0480-5</pub-id>
<pub-id pub-id-type="pmid">25273974</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shihab</surname>
<given-names>HA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrative approach to predicting the functional effects of non-coding and coding sequence variation</article-title>
<source/>Bioinformatics
          <year>2015</year>
<volume>31</volume>
<fpage>1536</fpage>
<lpage>1543</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id>
<pub-id pub-id-type="pmid">25583119</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smedley</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A whole-genome analysis framework for effective identification of pathogenic regulatory variants in mendelian disease</article-title>
<source/>Am. J. Hum. Genet.
          <year>2016</year>
<volume>99</volume>
<fpage>595</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.07.005</pub-id>
<pub-id pub-id-type="pmid">27569544</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Troyanskaya</surname>
<given-names>OG</given-names>
</name>
</person-group>
<article-title>Predicting effects of noncoding variants with deep learning-based sequence model</article-title>
<source/>Nat. Methods
          <year>2015</year>
<volume>12</volume>
<fpage>931</fpage>
<lpage>934</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.3547</pub-id>
<pub-id pub-id-type="pmid">26301843</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gussow</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Orion: detecting regions of the human non-coding genome that are intolerant to variation using population genetics</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<fpage>e0181604</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0181604</pub-id>
<pub-id pub-id-type="pmid">28797091</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Gulko</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Siepel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data</article-title>
<source/>Nat. Genet.
          <year>2017</year>
<volume>49</volume>
<fpage>618</fpage>
<lpage>624</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3810</pub-id>
<pub-id pub-id-type="pmid">28288115</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rokach</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Ensemble-based classifiers</article-title>
<source/>Artif. Intell. Rev.
          <year>2010</year>
<volume>33</volume>
<fpage>1</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1007/s10462-009-9124-7</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>di Iulio</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The human noncoding genome defined by genetic diversity</article-title>
<source/>Nat. Genet.
          <year>2018</year>
<volume>50</volume>
<fpage>333</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1038/s41588-018-0062-7</pub-id>
<pub-id pub-id-type="pmid">29483654</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A high-resolution map of the three-dimensional chromatin interactome in human cells</article-title>
<source/>Nature
          <year>2013</year>
<volume>503</volume>
<fpage>290</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1038/nature12644</pub-id>
<pub-id pub-id-type="pmid">24141950</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mifsud</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C</article-title>
<source/>Nat. Genet.
          <year>2015</year>
<volume>47</volume>
<fpage>598</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3286</pub-id>
<pub-id pub-id-type="pmid">25938943</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>CD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide quantitative enhancer activity maps identified by STARR-seq</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>1074</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="doi">10.1126/science.1232542</pub-id>
<pub-id pub-id-type="pmid">23328393</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landrum</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ClinVar: public archive of interpretations of clinically relevant variants</article-title>
<source/>Nucleic Acids Res.
          <year>2016</year>
<volume>44</volume>
<fpage>D862</fpage>
<lpage>D868</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1222</pub-id>
<pub-id pub-id-type="pmid">26582918</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenson</surname>
<given-names>PD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies</article-title>
<source/>Hum. Genet.
          <year>2017</year>
<volume>136</volume>
<fpage>665</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-017-1779-6</pub-id>
<pub-id pub-id-type="pmid">28349240</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petrovski</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intolerance of regulatory sequence to genetic variation predicts gene dosage sensitivity</article-title>
<source/>PLoS Genet.
          <year>2015</year>
<volume>11</volume>
<fpage>e1005492</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005492</pub-id>
<pub-id pub-id-type="pmid">26332131</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulco</surname>
<given-names>CP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systematic mapping of functional enhancer-promoter connections with CRISPR interference</article-title>
<source/>Science
          <year>2016</year>
<volume>354</volume>
<fpage>769</fpage>
<lpage>773</lpage>
<pub-id pub-id-type="doi">10.1126/science.aag2445</pub-id>
<pub-id pub-id-type="pmid">27708057</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diao</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells</article-title>
<source/>Nat. Methods
          <year>2017</year>
<volume>14</volume>
<fpage>629</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.4264</pub-id>
<pub-id pub-id-type="pmid">28417999</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>The role of de novo noncoding regulatory mutations in neurodevelopmental disorders</article-title>
<source/>Trends Neurosci.
          <year>2019</year>
<volume>42</volume>
<fpage>115</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2018.11.002</pub-id>
<pub-id pub-id-type="pmid">30563709</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klopocki</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy-number variations involving the IHH locus are associated with syndactyly and craniosynostosis</article-title>
<source/>Am. J. Hum. Genet.
          <year>2011</year>
<volume>88</volume>
<fpage>70</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.11.006</pub-id>
<pub-id pub-id-type="pmid">21167467</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barroso</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of the fourth duplication of upstream IHH regulatory elements, in a family with craniosynostosis Philadelphia type, helps to define the phenotypic characterization of these regulatory elements</article-title>
<source/>Am. J. Med. Genet. A
          <year>2015</year>
<volume>167A</volume>
<fpage>902</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36811</pub-id>
<pub-id pub-id-type="pmid">25692887</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Will</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Composition and dosage of a multipartite enhancer cluster control developmental expression of Ihh (Indian hedgehog)</article-title>
<source/>Nat. Genet.
          <year>2017</year>
<volume>49</volume>
<fpage>1539</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3939</pub-id>
<pub-id pub-id-type="pmid">28846100</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">Dall’Agnese, A. et al. Transcription factor-directed re-wiring of chromatin architecture for somatic cell nuclear reprogramming toward trans-differentiation. <italic>Mol. Cell</italic>. pii: S1097-2765(19)30591-X (2019). 10.1016/j.molcel.2019.07.036 [Epub ahead of print].</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caron</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rausell</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>NCBoost classifies pathogenic non-coding variants in Mendelian diseases through supervised learning on purifying selection signals in humans</article-title>
<source/>Genome Biol.
          <year>2019</year>
<volume>20</volume>
<fpage>32</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-019-1634-2</pub-id>
<pub-id pub-id-type="pmid">30744685</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osterwalder</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhancer redundancy provides phenotypic robustness in mammalian development</article-title>
<source/>Nature
          <year>2018</year>
<volume>554</volume>
<fpage>239</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1038/nature25461</pub-id>
<pub-id pub-id-type="pmid">29420474</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Marcotte</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Hurles</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>
<source/>PLoS Genet.
          <year>2010</year>
<volume>6</volume>
<fpage>e1001154</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1001154</pub-id>
<pub-id pub-id-type="pmid">20976243</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>HL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ClinGen–the Clinical Genome Resource</article-title>
<source/>N. Engl. J. Med.
          <year>2015</year>
<volume>372</volume>
<fpage>2235</fpage>
<lpage>2242</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMsr1406261</pub-id>
<pub-id pub-id-type="pmid">26014595</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An informatics approach to analyzing the incidentalome</article-title>
<source/>Genet. Med.
          <year>2013</year>
<volume>15</volume>
<fpage>36</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2012.112</pub-id>
<pub-id pub-id-type="pmid">22995991</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blekhman</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Natural selection on genes that underlie human disease susceptibility</article-title>
<source/>Curr. Biol.
          <year>2008</year>
<volume>18</volume>
<fpage>883</fpage>
<lpage>889</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2008.04.074</pub-id>
<pub-id pub-id-type="pmid">18571414</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Amberger</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bocchini</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>McKusick</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders</article-title>
<source/>Nucleic Acids Res.
          <year>2005</year>
<volume>33</volume>
<fpage>D514</fpage>
<lpage>D517</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gki033</pub-id>
<pub-id pub-id-type="pmid">15608251</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<fpage>1665</fpage>
<lpage>1680</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.11.021</pub-id>
<pub-id pub-id-type="pmid">25497547</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitt</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A compendium of chromatin contact maps reveals spatially active regions in the human genome</article-title>
<source/>Cell Rep.
          <year>2016</year>
<volume>17</volume>
<fpage>2042</fpage>
<lpage>2059</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.061</pub-id>
<pub-id pub-id-type="pmid">27851967</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An atlas of active enhancers across human cell types and tissues</article-title>
<source/>Nature
          <year>2014</year>
<volume>507</volume>
<fpage>455</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1038/nature12787</pub-id>
<pub-id pub-id-type="pmid">24670763</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consortium</surname>
<given-names>GT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic effects on gene expression across human tissues</article-title>
<source/>Nature
          <year>2017</year>
<volume>550</volume>
<fpage>204</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1038/nature24277</pub-id>
<pub-id pub-id-type="pmid">29022597</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muerdter</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resolving systematic errors in widely used enhancer activity assays in human cells</article-title>
<source/>Nat. Methods
          <year>2018</year>
<volume>15</volume>
<fpage>141</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.4534</pub-id>
<pub-id pub-id-type="pmid">29256496</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Minovitsky</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dubchak</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pennacchio</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>VISTA Enhancer Browser–a database of tissue-specific human enhancers</article-title>
<source/>Nucleic Acids Res.
          <year>2007</year>
<volume>35</volume>
<fpage>D88</fpage>
<lpage>D92</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkl822</pub-id>
<pub-id pub-id-type="pmid">17130149</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hon</surname>
<given-names>CC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An atlas of human long non-coding RNAs with accurate 5′ ends</article-title>
<source/>Nature
          <year>2017</year>
<volume>543</volume>
<fpage>199</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1038/nature21374</pub-id>
<pub-id pub-id-type="pmid">28241135</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neph</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BEDOPS: high-performance genomic feature operations</article-title>
<source/>Bioinformatics
          <year>2012</year>
<volume>28</volume>
<fpage>1919</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts277</pub-id>
<pub-id pub-id-type="pmid">22576172</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>